On November 17, 2022, results from a phase 3 trial of DCVax-L, an immunotherapy for glioblastoma patients, were published in the Journal of the American Medical Association (JAMA) Oncology.
Vince Rock answers the top questions he receives from patients and caregivers who call the ABTA CareLine.
As we welcome 2023, it’s a time to embrace the new year and new ways to get involved and make an impact in the brain tumor community.
Meet two researchers on opposite ends of the globe dedicated to transforming the future of brain tumor treatments.
**Sponsored Content**
Chris traveled across the country for a minimally invasive “keyhole” procedure to remove his large meningioma. Read why he chose Dr. Daniel Kelly at Pacific Neuroscience Institute (PNI) for his brain surgery.
Go behind the scenes of the nation’s largest brain tumor conference and hear why the co-chairs say you don’t want to miss this year’s event, Sept. 9-10!
Dr. Duane Mitchell, MD, PhD, Univ. of Florida, shares four highlights in recent GBM research and what he’s hopeful for in the future.
**Sponsored Content**
See how Mary is defying the odds years after her initial glioblastoma diagnosis and how she found peace of mind through GammaTile Therapy, a one-time, targeted radiation treatment.
Engage with your community and learn about the latest treatment advances at the ABTA National Conference, September 9-10.
American Brain Tumor Association
8550 W. Bryn Mawr Ave. Ste 550
Chicago, IL 60631
